EP0000148A1 - Quinazolinone oxides and process for their preparation - Google Patents
Quinazolinone oxides and process for their preparation Download PDFInfo
- Publication number
- EP0000148A1 EP0000148A1 EP78100162A EP78100162A EP0000148A1 EP 0000148 A1 EP0000148 A1 EP 0000148A1 EP 78100162 A EP78100162 A EP 78100162A EP 78100162 A EP78100162 A EP 78100162A EP 0000148 A1 EP0000148 A1 EP 0000148A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- compound
- quinazolinone
- oxide
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
Definitions
- starting material (1) can be prepared by the process disclosed in U.S. Patent No. 3,398,139.
- the present invention relates to an improved process for making such N-methylaminobenzophenone anti-oximes, and novel intermediates used in the improved process.
- the present invention relates to a new process for the preparation of N-methylaminobenzophenone anti-oximes by alkylation, and subsequent hydrolysis, of the corresponding quinazoline oxides.
- the preparation of compounds of Formula III is accomplished in two interrelated stages.
- reaction products of Formula II (X, Y as defined) are then hydrolytically converted in the presence of base to the methylaminobenzophenone anti-oximes of Formula III (X, Y as defined).
- compounds of formula II which are preferred as intermediates are those where X is chlorine or bromine. More preferred compounds of formula II are those where X is chlorine or bromine and Y is hydrogen, chlorine or fluorine.
- Most preferred compounds are those where X is chlorine or bromine and Y is hydrogen or fluorine.
- 1-Methylquinazolinone oxides of Formula II can be prepared by treating a solution or mixture of a compound of Formula I, prepared as taught by Sulkowski and Childress, J. Org. Chem., 27 4424 (1962) or by the improved process disclosed by Middleton in copending U.S. Patent Application Serial Number filed simultaneously herewith (attorney's docket number CR-7794), and a suitable base with an alkylating agent in an inert organic solvent medium.
- the reaction is preferentially carried out at moderate temperatures of 50-75°, but this step can be effected at room temperature.or above.
- Suitable solvents include, but are not limited to, ethers such as tetrahydrofuran,.diethyl ether and glyme; amides of secondary amines such as N,N-dimethylformamide and N,N-dimethylacetamide.
- Representative bases useful in the generation of the alkali metal salt of a compound of Formula I include, but are not limited to, potassium carbonate, sodium hydride, sodium carbonate and sodium or potassium alkoxides such as sodium ethoxide or methoxide.
- the alkylated quinazolinone oxides can be isolated from the reaction mixture by conventional means, such as filtration of the insoluble product.
- the compound of Formula II can then be converted to the anti-oxime by heating with a base in an aqueous- alcoholic solvent.
- a base in an aqueous- alcoholic solvent.
- the reaction is conveniently carried out at the reflux temperature of the solvent.
- Useful alcoholic solvents include, but are not limited to, ethanol, methanol, propanol, isopropanol, butanol, 2-methoxyethanol, ethylene glycol and propylene glycol.
- suitable bases are alkali metal (such as sodium and potassium) hydroxides, carbonates and bicarbonates.
- the alkylaminobenzophenone anti-oximes obtained can be purified by evaporation of the reaction solvent and recrystallization of the solid residue.
- the yellow solid was dissolved in 350 ml of hot 1-chlorobutane. This hot viscous solution was filtered through a coarse fritted glass funnel. The filter and empty flask were thoroughly rinsed with exactly 150 ml of 1-chlorobutane and added to the filtrate. A total of only 500 ml of 1-chlorobutane was used. On addition of 2,000 ml of hexane to the chlorobutane solution, the desired product precipitated out.
- the anti-5-chloro-2-(N-methylamino)benzophenone oxime was obtained either in 88% yield (crystalline form "a", m.p. 90-91°) or 80% yield (crystalline form "b", m.p.
- the anti-oxime obtained exists in two different crystalline modifications. Their solid infrared spectra differ, as do color and solubility. The least soluble crystalline form, "a” precipitates out immediately on addition of hexane to the 1-chlorobutane solution. It is quite yellow, fluffy and obtained in good yield. The crystalline form "b” is more soluble and is obtained when hexane addition does not cause rapid precipitation, but rather a slow crystallization which requires thorough cooling. The material is pale yellow and crystalline.
- Table I shows additional 1-methylquinazolinone 3-oxides that can be prepared by the processes disclosed and illustrated above using the appropriate quinazolinone 3-oxide and a suitable methylating agent.
- Table II shows additional methylaminobenzophenone anti-oximes that can be prepared by the processes disclosed and illustrated above using the appropriate 1-methylquinazolinone 3-oxide and a suitable base.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/807,074 US4160092A (en) | 1977-06-16 | 1977-06-16 | Quinazolinone oxides and their use as intermediates for pharmaceutical agents |
US807074 | 2007-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0000148A1 true EP0000148A1 (en) | 1979-01-10 |
Family
ID=25195499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78100162A Withdrawn EP0000148A1 (en) | 1977-06-16 | 1978-06-15 | Quinazolinone oxides and process for their preparation |
Country Status (17)
Country | Link |
---|---|
US (1) | US4160092A (es) |
EP (1) | EP0000148A1 (es) |
JP (1) | JPS545989A (es) |
AR (1) | AR218668A1 (es) |
AT (1) | AT359057B (es) |
AU (1) | AU3713878A (es) |
DK (1) | DK176478A (es) |
ES (1) | ES470829A1 (es) |
FI (1) | FI781929A (es) |
GR (1) | GR64974B (es) |
IL (1) | IL54922A0 (es) |
IT (1) | IT1098333B (es) |
NO (1) | NO782086L (es) |
NZ (1) | NZ187582A (es) |
PT (1) | PT68173A (es) |
SU (1) | SU731893A3 (es) |
ZA (1) | ZA783440B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5684735U (es) * | 1979-12-03 | 1981-07-08 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754246A (en) * | 1970-07-31 | 1970-12-31 | Sumitomo Chemical Co | Novel quinazoline derivs prepn |
CH573412A5 (en) * | 1971-08-17 | 1976-03-15 | Sumitomo Chemical Co | 1-substd 4-aryl-2(1h) quinazolinones - anti-inflammatories, analgesics, uricosurics, andantivirals |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BG16042A3 (bg) * | 1968-11-12 | 1972-05-20 | Nans Ott | Метод за получаване на нови 2(1н)-хиназолинони |
-
1977
- 1977-06-16 US US05/807,074 patent/US4160092A/en not_active Expired - Lifetime
-
1978
- 1978-04-24 DK DK176478A patent/DK176478A/da not_active Application Discontinuation
- 1978-06-09 AR AR272533A patent/AR218668A1/es active
- 1978-06-15 ES ES470829A patent/ES470829A1/es not_active Expired
- 1978-06-15 NZ NZ187582A patent/NZ187582A/xx unknown
- 1978-06-15 ZA ZA00783440A patent/ZA783440B/xx unknown
- 1978-06-15 PT PT68173A patent/PT68173A/pt unknown
- 1978-06-15 AU AU37138/78A patent/AU3713878A/en active Pending
- 1978-06-15 EP EP78100162A patent/EP0000148A1/en not_active Withdrawn
- 1978-06-15 IT IT24614/78A patent/IT1098333B/it active
- 1978-06-15 NO NO782086A patent/NO782086L/no unknown
- 1978-06-15 IL IL7854922A patent/IL54922A0/xx unknown
- 1978-06-15 AT AT436778A patent/AT359057B/de not_active IP Right Cessation
- 1978-06-16 SU SU782626798A patent/SU731893A3/ru active
- 1978-06-16 GR GR56540A patent/GR64974B/el unknown
- 1978-06-16 FI FI781929A patent/FI781929A/fi not_active Application Discontinuation
- 1978-06-16 JP JP7368078A patent/JPS545989A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754246A (en) * | 1970-07-31 | 1970-12-31 | Sumitomo Chemical Co | Novel quinazoline derivs prepn |
CH573412A5 (en) * | 1971-08-17 | 1976-03-15 | Sumitomo Chemical Co | 1-substd 4-aryl-2(1h) quinazolinones - anti-inflammatories, analgesics, uricosurics, andantivirals |
Also Published As
Publication number | Publication date |
---|---|
DK176478A (da) | 1978-12-17 |
NZ187582A (en) | 1980-11-28 |
AR218668A1 (es) | 1980-06-30 |
AU3713878A (en) | 1979-12-20 |
AT359057B (de) | 1980-10-27 |
JPS545989A (en) | 1979-01-17 |
ES470829A1 (es) | 1979-10-01 |
ATA436778A (de) | 1980-03-15 |
SU731893A3 (ru) | 1980-04-30 |
IT7824614A0 (it) | 1978-06-15 |
ZA783440B (en) | 1979-06-27 |
GR64974B (en) | 1980-06-11 |
PT68173A (en) | 1978-07-01 |
IT1098333B (it) | 1985-09-07 |
NO782086L (no) | 1978-12-19 |
IL54922A0 (en) | 1978-08-31 |
US4160092A (en) | 1979-07-03 |
FI781929A (fi) | 1978-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103342633B (zh) | 用于制备苯并呋喃类化合物的方法 | |
BG62554B1 (bg) | Метод за получаване на силденафил | |
EP2349964B1 (de) | Dibenzocycloheptanonderivate und pharmazeutische mittel, welche diese verbindungen enthalten | |
DE60025803T2 (de) | Herstellung von sulfonamiden | |
US6187926B1 (en) | Process for producing quinolone derivatives | |
SG172267A1 (en) | Process for the preparation of anagrelide and analogues | |
KR20180116371A (ko) | 4-알콕시-3-히드록시피콜린산의 제조 방법 | |
JPH0699396B2 (ja) | 新規オキサゾロピリジン誘導体 | |
EP0000148A1 (en) | Quinazolinone oxides and process for their preparation | |
US4194049A (en) | 2-[[2-Methyl-1-[2-benzoyl(or benzyl)phenyl]-1H-imidazol-5-yl]methyl]-1H-isoindole-1,3(2H)-diones | |
LEONARD et al. | SOME NOVEL REACTIONS OF 4-QUINAZOLONE1, 2 | |
EP0273321B1 (en) | 7-bromo-beta-carboline compound and method for producing same | |
DE69012881T2 (de) | Herstellung von N-(3-(((aryl)amino)sulfonyl)-1H-1,2,4-triazol-5-yl)aminen. | |
Heyman | Preparation of isatoates from isatoic anhydride | |
HU202813B (en) | Process for producing dialkyl-acetals containing keto-groups | |
WO2003053900A1 (de) | Verfahren zur herstellung von deoxybenzoinen | |
PL75399B3 (en) | Certain 2,4-diamino-5-benzyl-6-alkylthiopyrimidines[us3822264a] | |
US3262975A (en) | 1-chloro-3, 4-dihydro 2-naphthaldehyde oxime and ethers thereof | |
US4313950A (en) | Antireproductive tricyclic ortho-fused nitrogen containing compounds | |
DK156391B (da) | Analogifremgangsmaade til fremstilling af 3-aminopyrrolderivater | |
US3590044A (en) | Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2-carboxamidines | |
Straub | Regioselective metalation of ortho-aminopicolines using the pivaloyl group as a directing group: synthesis of naphthyridines | |
JP3005080B2 (ja) | シクロペンタ[d]ピリミジン−4−オン類の製造方法 | |
CN117886725A (zh) | 一种阿普斯特中间体的制备工艺 | |
KR810001891B1 (ko) | 페닐 에틸 아민류의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE Kind code of ref document: A1 Designated state(s): BE CH DE FR GB LU NL SE |
|
17P | Request for examination filed | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19810403 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BINGHAM, ELENA MARIA Inventor name: ELLIOT, ARTHUR JOHN |